Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.

Bone morphogenetic protein (BMP)-6 is a member of the transforming growth factor (TGF)-(&bgr;) superfamily, and is most similar to BMP-5, osteogenic protein (OP)-1/BMP-7, and OP-2/BMP-8. In the present study, we characterized the endogenous BMP-6 signaling pathway during osteoblast differentiation. BMP-6 strongly induced alkaline phosphatase (ALP) activity in cells of osteoblast lineage, including C2C12 cells, MC3T3-E1 cells, and ROB-C26 cells. The profile of binding of BMP-6 to type I and type II receptors was similar to that of OP-1/BMP-7 in C2C12 cells and MC3T3-E1 cells; BMP-6 strongly bound to activin receptor-like kinase (ALK)-2 (also termed ActR-I), together with type II receptors, i.e. BMP type II receptor (BMPR-II) and activin type II receptor (ActR-II). In addition, BMP-6 weakly bound to BMPR-IA (ALK-3), to which BMP-2 also bound. In contrast, binding of BMP-6 to BMPR-IB (ALK-6), and less efficiently to ALK-2 and BMPR-IA, together with BMPR-II was detected in ROB-C26 cells. Intracellular signalling was further studied using C2C12 and MC3T3-E1 cells. Among the receptor-regulated Smads activated by BMP receptors, BMP-6 strongly induced phosphorylation and nuclear accumulation of Smad5, and less efficiently those of Smad1. However, Smad8 was constitutively phosphorylated, and no further phosphorylation or nuclear accumulation of Smad8 by BMP-6 was observed. These findings indicate that in the process of differentiation to osteoblasts, BMP-6 binds to ALK-2 as well as other type I receptors, and transduces signals mainly through Smad5 and possibly through Smad1.

[1]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[2]  C. Heldin,et al.  Intracellular signaling of osteogenic protein‐1 through Smad5 activation , 1998, Journal of Cellular Physiology.

[3]  P. Hoodless,et al.  Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.

[4]  Takeshi Imamura,et al.  Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.

[5]  K. Miyazono,et al.  Identification of a Novel Bone Morphogenetic Protein-responsive Gene That May Function as a Noncoding RNA* , 1998, The Journal of Biological Chemistry.

[6]  K. Miyazono,et al.  Interaction of Drosophila Inhibitors of Apoptosis with Thick Veins, a Type I Serine/Threonine Kinase Receptor for Decapentaplegic* , 1998, The Journal of Biological Chemistry.

[7]  J. Wrana,et al.  Mads and Smads in TGFβ signalling , 1998 .

[8]  K. Miyazono,et al.  Signal transduction by bone morphogenetic proteins. , 1998, Cytokine & growth factor reviews.

[9]  T. Yoneda,et al.  Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.

[10]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[11]  J. Massagué,et al.  TGF- SIGNAL TRANSDUCTION , 1998 .

[12]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[13]  W. Vale,et al.  Smad8 mediates the signaling of the receptor serine kinase , 1997 .

[14]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[15]  Naoya Yamamoto,et al.  Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. , 1997, Biochemical and biophysical research communications.

[16]  R. Derynck,et al.  A kinase subdomain of transforming growth factor‐β (TGF‐β) type I receptor determines the TGF‐β intracellular signaling specificity , 1997 .

[17]  X. F. Wang,et al.  Smad5 induces ventral fates in Xenopus embryo. , 1997, Developmental biology.

[18]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-beta superfamily. , 1997, Nature.

[19]  G. Thomsen.  Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. , 1996, Development.

[20]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[21]  P. Hoodless,et al.  MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways , 1996, Cell.

[22]  J. Graff,et al.  Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ Superfamily , 1996, Cell.

[23]  T. Atsumi,et al.  Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor , 1996, The Journal of cell biology.

[24]  V. Rosen,et al.  Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. , 1996, Biochemical and biophysical research communications.

[25]  S. Noji,et al.  Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors (*) , 1995, The Journal of Biological Chemistry.

[26]  K. Miyazono,et al.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[28]  J. Smith,et al.  Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects , 1995, The Journal of cell biology.

[29]  R. Derynck,et al.  Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[30]  H. Moses,et al.  Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor (*) , 1995, The Journal of Biological Chemistry.

[31]  A. Reddi.  Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.

[32]  R. Derynck,et al.  Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo , 1994, The Journal of cell biology.

[33]  J. Massagué,et al.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.

[34]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[35]  K. Miyazono,et al.  Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.

[36]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[37]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[38]  K. Miyazono,et al.  Characterization of in vivo phosphorylation of activin type II receptor. , 1993, Biochemical and biophysical research communications.

[39]  H. Kleinman,et al.  Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen , 1992, The Journal of cell biology.

[40]  B. Hogan,et al.  Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. , 1991, Development.

[41]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Hogan,et al.  Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. , 1989, Genes & development.